PMC Links for Books (Select 4863606) - PMC

Result Filters

Links from Books

Items: 10

Select item 83767841.

Effect of SLCO1B1 T521C on Statin-related Myotoxicity with Use of Lovastatin and Atorvastatin

Brian Lu, Laura Sun, Manuel Seraydarian, Thomas J. Hoffmann, Marisa W. Medina, Carlos Iribarren, Ronald M. Krauss, Neil Risch, Akinyemi Oni-Orisan

Clin Pharmacol Ther. Author manuscript; available in PMC 2022 Sep 1.

Published in final edited form as: Clin Pharmacol Ther. 2021 Sep; 110(3): 733–740. Published online 2021 Jul 23. doi: 10.1002/cpt.2337

Correction in:: Clin Pharmacol Ther. 2023 Feb 25

PMCID:: PMC8376784

Abstract Article PDF–421K

Select item 82790372.

Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses

Ting Cai, Lucy Abel, Oliver Langford, Genevieve Monaghan, Jeffrey K Aronson, Richard J Stevens, Sarah Lay-Flurrie, Constantinos Koshiaris, Richard J McManus, F D Richard Hobbs, James P Sheppard

BMJ. 2021; 374: n1537. Published online 2021 Jul 15. doi: 10.1136/bmj.n1537

PMCID:: PMC8279037

Abstract Article

Select item 79679633.

A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis

Shuen Sung, Mustafa Al-Karaghouli, Sylvia Kalainy, Lourdes Cabrera Garcia, Juan G. Abraldes

BMC Gastroenterol. 2021; 21: 120. Published online 2021 Mar 16. doi: 10.1186/s12876-021-01704-w

PMCID:: PMC7967963

Abstract Article PDF–1.6M

Select item 75445374.

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom

Jemma C Hopewell, Alison Offer, Richard Haynes, Louise Bowman, Jing Li, Fang Chen, Richard Bulbulia, Mark Lathrop, Colin Baigent, Martin J Landray, Rory Collins, Jane Armitage, Sarah Parish

Eur Heart J. 2020 Sep 14; 41(35): 3336–3342. Published online 2020 Jul 23. doi: 10.1093/eurheartj/ehaa574

PMCID:: PMC7544537

Abstract Article PDF–613K

Select item 58598515.

Effect of Stains on LDL Reduction and Liver Safety: A Systematic Review and Meta-Analysis

Xiao Liang, Qin He, Qinghua Zhao

Biomed Res Int. 2018; 2018: 7092414. Published online 2018 Mar 5. doi: 10.1155/2018/7092414

PMCID:: PMC5859851

Abstract Article PDF–1002K

Select item 58149876.

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial

Robert P. Giugliano, Stephen D. Wiviott, Michael A. Blazing, Gaetano M. De Ferrari, Jeong-Gun Park, Sabina A. Murphy, Jennifer A. White, Andrew M. Tershakovec, Christopher P. Cannon, Eugene Braunwald

JAMA Cardiol. 2017 May; 2(5): 547–555. Published online 2017 Mar 14. doi: 10.1001/jamacardio.2017.0083

PMCID:: PMC5814987

Abstract Article

Select item 53381257.

Statin‐induced liver injury in an area endemic for hepatitis B virus infection: risk factors and outcome analysis

Li Yueh Wang, Yi‐Shin Huang, Chin‐Lin Perng, Bryan Huang, Han‐Chieh Lin

Br J Clin Pharmacol. 2016 Sep; 82(3): 823–830. Published online 2016 Jun 17. doi: 10.1111/bcp.13009

PMCID:: PMC5338125

Abstract Article PDF–399K

Select item 44462358.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006